Analog Devices is at a turning point, with revenue and margin recovery underway after a challenging 2024. Click here to find ...

VESPER-1 and interim VESPER-3 data release expected in September 2025; Phase 3 initiation on track for late 2025 MET-233i (once-monthly amylin analog) delivered ...

6. Rhodonite Indicator Discovery Although not part of the original U of C study, ESGold's recent discovery of rhodonite - a manganese-rich metamorphic mineral commonly associated with Broken Hill-type ...

Shares of manufacturer of analog chips Analog Devices (NASDAQ:ADI) fell 3.2% in the morning session after a weak profit ...

Morgan Stanley analyst Joseph Moore maintained a Buy rating on Analog Devices today and set a price target of $273.00. The company’s shares opened today at $238.75. Take advantage of TipRanks Premium ...

Texas Instruments forecast third-quarter revenue above Wall Street estimates on Tuesday, signaling recovering demand for its analog chips even as U.S. tariff negotiations lead to macroeconomic ...

Seven-Site Pilot Spanning Pharma, Facility Management, Energy and Utilities to Validate AI Nose as Next-Gen Industrial AI at ScaleRobots Gain a New Sense: AI Nose Leverages Smell Language Model for Sm ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

The fact that multiple Analog Devices, Inc. ( NASDAQ:ADI ) insiders offloaded a considerable amount of shares over ...

Pharvaris' innovative approach to treating hereditary angioedema (HAE) with deucrictibant. Read here for an investment analysis of PHVS stock.